Nachman Norwood & Parrott’s Genmab GMAB Stock Holding History

Nachman Norwood & Parrott’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-222	Closed	-$8K	–	561
2020 Q3	$8K	Buy	+222	New	+$8.03K	﹤0.01%	816

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nachman Norwood & Parrott's GMAB Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Genmab (GMAB) in Q4 2020, closing a stake of 222 shares — an estimated $8K sold.

Nachman Norwood & Parrott first reported a position in GMAB in Q3 2020 and held it in 1 quarter. The position peaked at $8K in Q3 2020. 227 funds tracked by Wall St. Rank hold GMAB as of Q4 2020.

Nachman Norwood & Parrott reported no remaining Genmab position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 222 Genmab shares in Q4 2020, an estimated $8K.
Nachman Norwood & Parrott first reported a position in Genmab in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's Genmab position peaked at $8K in Q3 2020.
227 funds tracked by Wall St. Rank held Genmab as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.